Asthma
Not recruitingStudy on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma
- Disease:Asthma
- Substances:GSK5784283
Bulgaria- Participants:18–64 years · 65+ years
- Substances:GSK5784283
- Sponsor:Glaxosmithkline Research & Development Limited
Rare diseases
Investigational molecules
Locations
Back to Bulgaria32 clinical trials in Gorna Oryahovitsa, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on uncontrolled asthma management and innovative treatments to improve respiratory function. Research includes evaluation of novel antibody therapies and their effects on exhaled biomarkers.
Groundbreaking trials investigating treatments for atherosclerotic cardiovascular disease and stroke prevention. Studies evaluate new therapies for reducing major adverse cardiovascular events and improving patient outcomes.
Comprehensive research into inflammatory bowel conditions, including Crohn's disease and ulcerative colitis. Studies focus on developing new therapeutic approaches for moderate to severe disease states.
Vital research addressing COVID-19 and C. difficile infections. Studies include pediatric treatments and prevention strategies for recurring infections.
Advanced studies on metabolic dysfunction-associated steatohepatitis and liver conditions. Research focuses on innovative treatments for fibrosis regression and improving liver health outcomes.
Innovative research targeting neovascular age-related macular degeneration. Studies compare treatment efficacy and visual acuity improvements in patients with retinal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.